Advertisement

Topics

Samsung's Biosimilar Manufacturing Documents Lead Janssen To Drop Infringement Suit

12:08 EST 14 Nov 2017 | Elsevier Business Intelligence

Janssen concludes the manufacturing processes for Renflexis do not infringe its Remicade patents, clearing Samsung and partne...

Original Article: Samsung's Biosimilar Manufacturing Documents Lead Janssen To Drop Infringement Suit

NEXT ARTICLE

More From BioPortfolio on "Samsung's Biosimilar Manufacturing Documents Lead Janssen To Drop Infringement Suit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...